These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 9219786

  • 1. Eradication of H. pylori in a developing country: comparison of lansoprazole versus omeprazole with norfloxacin, in a dual-therapy study.
    Gupta VK, Dhar A, Srinivasan S, Rattan A, Sharma MP.
    Am J Gastroenterol; 1997 Jul; 92(7):1140-2. PubMed ID: 9219786
    [Abstract] [Full Text] [Related]

  • 2. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.
    Schwartz H, Krause R, Sahba B, Haber M, Weissfeld A, Rose P, Siepman N, Freston J.
    Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452
    [Abstract] [Full Text] [Related]

  • 3. [Comparative effect of lansoprazole/amoxicillin with omeprazole/amoxicillin for the eradication of Helicobacter pylori in patients with duodenal ulcer].
    Kayser S, Flury R, Zbinden R, Fried M, Wirth HP.
    Schweiz Med Wochenschr; 1997 Apr 26; 127(17):722-7. PubMed ID: 9221483
    [Abstract] [Full Text] [Related]

  • 4. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?
    Güliter S, Keleş H, Ozkurt ZN, Cengiz DU, Kolukisa E.
    Turk J Gastroenterol; 2005 Mar 26; 16(1):29-33. PubMed ID: 16252185
    [Abstract] [Full Text] [Related]

  • 5. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
    Asaka M, Kato M, Sugiyama T, Satoh K, Kuwayama H, Fukuda Y, Fujioka T, Takemoto T, Kimura K, Shimoyama T, Shimizu K, Kobayashi S, Japan Helicobacter pylori Eradication Study Group.
    J Gastroenterol; 2003 Mar 26; 38(4):339-47. PubMed ID: 12743773
    [Abstract] [Full Text] [Related]

  • 6. Continuous maintenance with low-dose lansoprazole versus Helicobacter pylori eradication in the prevention of duodenal ulcer recurrence.
    Parente F, Bargiggia S, Bollani S, Colombo E, Bianchi Porro G.
    Hepatogastroenterology; 1998 Mar 26; 45(22):990-3. PubMed ID: 9755995
    [Abstract] [Full Text] [Related]

  • 7. [Treatment of Helicobacter pylori infection with lansoprazole 30 mg or 60 mg combined with two antibiotics for duodenal ulcers].
    Lamouliatte H, Perie F, Joubert-Collin M.
    Gastroenterol Clin Biol; 2000 May 26; 24(5):495-500. PubMed ID: 10891736
    [Abstract] [Full Text] [Related]

  • 8. Effect of lansoprazole in mono-, dual-, or triple therapy on Helicobacter pylori eradication.
    Kawano S, Murakami M, Saita H, Tsuji S.
    J Gastroenterol; 1996 Nov 26; 31 Suppl 9():41-3. PubMed ID: 8959517
    [Abstract] [Full Text] [Related]

  • 9. Rank order of success favors longer duration of imidazole-based therapy for Helicobacter pylori in duodenal ulcer disease: a randomized pilot study.
    Chaudhary A, Ahuja V, Bal CS, Das B, Pandey RM, Sharma MP.
    Helicobacter; 2004 Apr 26; 9(2):124-9. PubMed ID: 15068413
    [Abstract] [Full Text] [Related]

  • 10. Lansoprazole and Helicobacter pylori infection.
    Pallone F, Luzza F, Delle Fave G, Annibale B, Marcheggiano A, Biancone L, Torsoli A, Capurso L.
    Clin Ther; 1993 Apr 26; 15 Suppl B():49-57. PubMed ID: 8205595
    [Abstract] [Full Text] [Related]

  • 11. Dual versus triple therapy in eradication of Helicobacter pylori.
    Ohlin B, Cederberg A, Kjellin T, Kullman E, Melén K, von Holstein CS, Thoring M.
    Hepatogastroenterology; 2002 Apr 26; 49(43):172-5. PubMed ID: 11941946
    [Abstract] [Full Text] [Related]

  • 12. [Helicobacter pylori and digestive hemorrhage due to duodenal ulcer: the prevalence of the infection, the efficacy of 3 triple therapies and the role of eradication in preventing a hemorrhagic recurrence].
    Gisbert JP, Boixeda D, Aller R, de la Serna C, Sanz E, Martín de Argila C, Abraira V, García Plaza A.
    Med Clin (Barc); 1999 Feb 13; 112(5):161-5. PubMed ID: 10091208
    [Abstract] [Full Text] [Related]

  • 13. A four-day low dose triple therapy regimen for the treatment of Helicobacter pylori infection.
    Trevisani L, Sartori S, Caselli M, Ruina M, Verdianelli G, Abbasciano V.
    Am J Gastroenterol; 1998 Mar 13; 93(3):390-3. PubMed ID: 9517646
    [Abstract] [Full Text] [Related]

  • 14. The importance of the level of metronidazole resistance for the success of Helicobacter pylori eradication.
    Wheeldon TU, Granström M, Hoang TT, Phuncarg DC, Nilsson LE, Sörberg M.
    Aliment Pharmacol Ther; 2004 Jun 15; 19(12):1315-21. PubMed ID: 15191514
    [Abstract] [Full Text] [Related]

  • 15. Dual therapy using a double dose of lansoprazole with amoxicillin versus triple therapy using a double dose of lansoprazole, amoxicillin, and clarithromycin to eradicate Helicobacter pylori infection: results of a prospective randomized open study.
    Lamouliatte H, Cayla R, Zerbib F, Forestier S, de Mascarel A, Joubert-Collin M, Mégraud F.
    Am J Gastroenterol; 1998 Sep 15; 93(9):1531-4. PubMed ID: 9732938
    [Abstract] [Full Text] [Related]

  • 16. One-week therapy with omeprazole, clarithromycin and metronidazole or ornidazole, followed by 3 weeks' treatment with omeprazole, eradicates Helicobacter pylori equally and heals duodenal ulcer.
    Tzivras M, Archimandritis A, Balatsos V, Delis V, Souyioultzis S, Skandalis N, Kanellopoulou E, Manika Z, Davaris P.
    Eur J Gastroenterol Hepatol; 1997 Dec 15; 9(12):1185-9. PubMed ID: 9471024
    [Abstract] [Full Text] [Related]

  • 17. Helicobacter pylori eradication in the healing and recurrence of benign gastric ulcer: a two-year, double-blind, placebo controlled study.
    Lazzaroni M, Perego M, Bargiggia S, Maconi G, Fiocca R, Solcia E, Franceschi M, Cesana B, Bianchi Porro G.
    Ital J Gastroenterol Hepatol; 1997 Jun 15; 29(3):220-7. PubMed ID: 9646213
    [Abstract] [Full Text] [Related]

  • 18. Multicenter evaluation of dual-therapy (omeprazol and amoxycillin) for Helicobacter pylori-associated duodenal and gastric ulcer (two years of the observation).
    Gabryelewicz A, Laszewicz W, Dzieniszewski J, Ciok J, Marlicz K, Bielecki D, Popiela T, Legutko J, Knapik Z, Poniewierka E.
    J Physiol Pharmacol; 1997 Sep 15; 48 Suppl 4():93-105. PubMed ID: 9440060
    [Abstract] [Full Text] [Related]

  • 19. Impact of Helicobacter pylori eradication on the anti-secretory efficacy of lansoprazole in gastroesophageal reflux disease patients.
    Giral A, Celikel CA, Ozdogan O, Tözün N, Ulusoy NB, Kalayci C.
    J Gastroenterol Hepatol; 2005 Dec 15; 20(12):1886-91. PubMed ID: 16336449
    [Abstract] [Full Text] [Related]

  • 20. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
    Lai KC, Chu KM, Hui WM, Wong BC, Hu WH, Wong WM, Chan AO, Wong J, Lam SK.
    Am J Med; 2005 Nov 15; 118(11):1271-8. PubMed ID: 16271912
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.